Global Metabolomics Market Size study, By Product (Metabolomics Instruments {Separation Techniques, Detection Techniques}, Metabolomics Bioinformatics Tools & Services), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Metabolic Disorders, Inborn Errors Of Metabolism, Other), By End-Use (Academic And Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Other), and Regional Forecasts 2022-2028
- BIZ4950948
- 200 Pages
- March 2022
- Diagnostic and Biotech
Metabolomics is a scientific study of chemical procedures that includes the small molecule substrates, intermediates and products of cell metabolism, and metabolites such as chromatography, spectroscopy, and multivariate. Metabolites are associated with the phenotype of an organism and utilizes in various applications like phenotyping of genetically modified plants, substantial equivalence testing, biotic-abiotic stress reaction analysis, and identification of gene function. Additionally, it also allows scientists and researchers to evaluate biological impacts and perceive the adverse reaction of drugs on an organism. The increasing availability of private and government funding for metabolomics research, and growing expenditure on pharmaceutical and biotech R&D activities are the primary factors for the market growth across the globe. The rising demand for personalized medicine, coupled with the increasing number of strategic movements such as mergers & acquisitions, by the leading market players are further surging the global market demand in the approaching years. For instance, in July 2021, the University of California, Davis (UC Davis), and Thermo Fisher Scientific, Inc. introduced the Center of Excellence in Clinical Metabolomics- a research associate to offer best practices, innovations, and standard operating measures to the metabolomics community. However, the complexity and diversity of biological samples and the high cost of tools and instruments impede the growth of the market over the forecast period of 2022-2028. Also, biomarker development and lucrative opportunities for market growth in emerging markets are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Metabolomics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing preclinical activities by CROs and pharmaceutical companies, tied with the increasing biomedical research. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as growing demand for improved pharmaceutical products, as well as the growth of the emerging economies, would create lucrative growth prospects for the Metabolomics Market across the Asia-Pacific region.
Major market players included in this report are:
Waters Corporation
Agilent Technologies
Shimadzu Corporation
Thermo Fisher Scientific
Danaher Corporation
Bruker Corporation
PerkinElmer
Merck KGaA
GE Healthcare
Hitachi High-Technologies Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Metabolomics Instruments
Separation Techniques
Detection Techniques
Metabolomics Bioinformatics Tools & Services
By Application:
Biomarker discovery
Drug discovery
Toxicology testing
Nutrigenomics
Functional Genomics
Personalized medicine
Other
By Indication:
Cancer
Cardiovascular Disorders
Neurological Disorders
Metabolic Disorders
Inborn Errors of Metabolism
Other
By End-Use:
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Other
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019,2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Metabolomics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Metabolomics Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Metabolomics Market, by Product & Service, 2020-2028 (USD Billion)
1.2.3. Global Metabolomics Market, by Application, 2020-2028 (USD Billion)
1.2.4. Global Metabolomics Market, by Indication, 2020-2028 (USD Billion)
1.2.5. Global Metabolomics Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Metabolomics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Metabolomics Market Dynamics
3.1. Metabolomics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Availability of government and private funding for metabolomics research
3.1.1.2. Increasing demand for personalized medicine
3.1.2. Market Challenges
3.1.2.1. Complexity and diversity of biological samples
3.1.2.2. High cost of tools and instruments
3.1.3. Market Opportunities
3.1.3.1. Biomarker development
3.1.3.2. Lucrative opportunities in emerging markets
Chapter 4. Global Metabolomics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Metabolomics Market, by Product & Service
6.1. Market Snapshot
6.2. Global Metabolomics Market by Product & Service, Performance - Potential Analysis
6.3. Global Metabolomics Market Estimates & Forecasts by Product & Service 2019-2028 (USD Billion)
6.4. Metabolomics Market, Sub Segment Analysis
6.4.1. Metabolomics Instruments
6.4.1.1. Separation Techniques
6.4.1.2. Detection Techniques
6.4.2. Metabolomics Bioinformatics Tools & Services
Chapter 7. Global Metabolomics Market, by Application
7.1. Market Snapshot
7.2. Global Metabolomics Market by Application, Performance - Potential Analysis
7.3. Global Metabolomics Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
7.4. Metabolomics Market, Sub Segment Analysis
7.4.1. Biomarker Discovery
7.4.2. Drug Discovery
7.4.3. Toxicology Testing
7.4.4. Nutrigenomics
7.4.5. Functional Genomics
7.4.6. Personalized medicine
7.4.7. Other
Chapter 8. Global Metabolomics Market, by Indication
8.1. Market Snapshot
8.2. Global Metabolomics Market by Indication, Performance - Potential Analysis
8.3. Global Metabolomics Market Estimates & Forecasts by Indication 2019-2028 (USD Billion)
8.4. Metabolomics Market, Sub Segment Analysis
8.4.1. Cancer
8.4.2. Cardiovascular Disorders
8.4.3. Neurological Disorders
8.4.4. Metabolic Disorders
8.4.5. Inborn Errors of Metabolism
8.4.6. Other
Chapter 9. Global Metabolomics Market, by End-Use
9.1. Market Snapshot
9.2. Global Metabolomics Market by End-Use, Performance - Potential Analysis
9.3. Global Metabolomics Market Estimates & Forecasts by End-Use 2019-2028 (USD Billion)
9.4. Metabolomics Market, Sub Segment Analysis
9.4.1. Academic and Research Institutes
9.4.2. Pharmaceutical & Biotechnology Companies
9.4.3. Contract Research Organizations
9.4.4. Other
Chapter 10. Global Metabolomics Market, Regional Analysis
10.1. Metabolomics Market, Regional Market Snapshot
10.2. North America Metabolomics Market
10.2.1. U.S. Metabolomics Market
10.2.1.1. Product & Service estimates & forecasts, 2019-2028
10.2.1.2. Application estimates & forecasts, 2019-2028
10.2.1.3. Indication estimates & forecasts, 2019-2028
10.2.1.4. End-Use estimates & forecasts, 2019-2028
10.2.2. Canada Metabolomics Market
10.3. Europe Metabolomics Market Snapshot
10.3.1. U.K. Metabolomics Market
10.3.2. Germany Metabolomics Market
10.3.3. France Metabolomics Market
10.3.4. Spain Metabolomics Market
10.3.5. Italy Metabolomics Market
10.3.6. Rest of Europe Metabolomics Market
10.4. Asia-Pacific Metabolomics Market Snapshot
10.4.1. China Metabolomics Market
10.4.2. India Metabolomics Market
10.4.3. Japan Metabolomics Market
10.4.4. Australia Metabolomics Market
10.4.5. South Korea Metabolomics Market
10.4.6. Rest of Asia Pacific Metabolomics Market
10.5. Latin America Metabolomics Market Snapshot
10.5.1. Brazil Metabolomics Market
10.5.2. Mexico Metabolomics Market
10.6. Rest of The World Metabolomics Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Waters Corporation
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product & Service Summary
11.2.1.5. Recent Developments
11.2.2. Agilent Technologies
11.2.3. Shimadzu Corporation
11.2.4. Thermo Fisher Scientific
11.2.5. Danaher Corporation
11.2.6. Bruker Corporation
11.2.7. PerkinElmer
11.2.8. Merck KGaA
11.2.9. GE Healthcare
11.2.10. Hitachi High-Technologies Corporation
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
TABLE 1. Global Metabolomics Market, report scope
TABLE 2. Global Metabolomics Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Metabolomics Market estimates & forecasts by Product & Service 2019-2028 (USD Billion)
TABLE 4. Global Metabolomics Market estimates & forecasts by Application 2019-2028 (USD Billion)
TABLE 5. Global Metabolomics Market estimates & forecasts by Indication 2019-2028 (USD Billion)
TABLE 6. Global Metabolomics Market estimates & forecasts by End-Use 2019-2028 (USD Billion)
TABLE 7. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 18. U.S. Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. U.S. Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 21. Canada Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. Canada Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 24. UK Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. UK Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 27. Germany Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. Germany Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 30. RoE Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. RoE Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 33. China Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. China Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 36. India Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. India Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 39. Japan Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. Japan Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 42. RoAPAC Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. RoAPAC Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 45. Brazil Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Brazil Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 48. Mexico Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. Mexico Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 51. RoLA Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. RoLA Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 54. Row Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. Row Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Metabolomics Market
TABLE 57. List of primary sources, used in the study of global Metabolomics Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
